Latest posts for the topic "1.3 IP Management and Deal Making for Global Health Outcomes: The New 'Return on Imagination' (ROI)"

1.3 IP Management and Deal Making for Global Health Outcomes: The New 'Return on Imagination' (ROI)

Admin — GMT

We welcome your comments on 1.3 IP Management and Deal Making for Global Health Outcomes: The New 'Return on Imagination' (ROI).

1.3 IP Management and Deal Making for Global Health Outcomes: The New 'Return on Imagination' (ROI)

Handbook Editors — GMT

The evolving domain of international health law encompasses increasingly diverse and complex concerns. Commentators
agree that health development in the twenty-first century is likely to expand the use of conventional international law to create a
framework for coordination and cooperation among states in an increasingly interdependent world. This article examines the forces and
factors behind the emerging expansion of conventional international health law as an important tool for present and future multilateral
cooperation. It considers challenges to effective international health cooperation posed for intergovernmental organizations and other
actors involved in lawmaking. Although full consolidation of all aspects of future international health lawmaking under the auspices of a
single international organization is unworkable and undesirable, the World Health Organization (WHO) should endeavour to serve as a
coordinator, catalyst and, where appropriate, platform for future health law codification. Such leadership by WHO could enhance
coordination, coherence and implementation of international health law policy.

1.3 IP Management and Deal Making for Global Health Outcomes: The New 'Return on Imagination' (ROI)

Handbook Editors — GMT

INTELLECTUAL PROPERTY AND PHARMACEUTICAL MARKETS: A NODAL GOVERNANCE APPROACH

Handbook Editors — GMT

National public goods have been part of the economic theory of government
for centuries. As any student of public policy knows, the idea that society
needs government to overcome the failures of the market in achieving efficiency
and equity in the allocation and distribution of resources is hardly new.
It is, moreover, a conservative idea. It assumes that private goods and services
will always constitute the bulk of people’s purchases.Markets must be allowed
to function. Yet some outside party must supply those “collective consumption
goods” that society also needs, but which the private sector has inadequate
incentives to provide.

Handbook Editors — GMT

In today’s world of globalisation, individual national societies cannot be understood in isolation from the processes occurring at the supranational level. National public policies and practices are always influenced by global factors. It is, however, clear that the relative roles of the different global parties involved in managing globalisation are in flux. International organisations dealing with economic, trade and financial policies seem to have ever-increasing visibility and power compared with those that deal with the social dimensions of globalisation.

1.3 IP Management and Deal Making for Global Health Outcomes: The New 'Return on Imagination' (ROI)

Handbook Editors — GMT

This document summarizes a workshop entitled,“Dealmaking and Intellectual Property Managementfor Public Interest,” organized by the Initiative on Public-Private Partnerships for Health (IPPPH) jointly with the Centre for Management of Intellectual Property in Health Research and Development (MIHR) and held on 29–30 November 2004, in Bethesda, Maryland, USA, at the offices of the Aeras Global TB Vaccine Foundation.

1.3 IP Management and Deal Making for Global Health Outcomes: The New 'Return on Imagination' (ROI)

Handbook Editors — GMT

Access to medicine is at the forefront of multilateral debates on
patent law. This paper argues that bilateralism allows the USA to circumvent
these debates and to set new international standards. Recently-concluded
US Free Trade Agreements (FTAs) impose more stringent conditions than the
Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPs)
requires. Although these ‘TRIPs-plus provisions’ are not technically
incompatible with the Doha Declaration on Public Health, they can be
considered as additional barriers for the entry of generic medicines.